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Worldwide, millions of people are exposed
to inorganic arsenic (iAs), a documented
potent human toxicant and carcinogen, via
drinking water [International Agency for
Research on Cancer (IARC) 2004; World
Health Organization (WHO)/International
Programme on Chemical Safety 2001]. The
British Geological Survey (BGS 2001) esti-
mated that about 50 million people in
Bangladesh alone are drinking water from
tube wells that exceeds the WHO drinking-
water guideline value for As of 10 µg/L.
There is a marked variation in susceptibility
to As, which—at least in part—may be
mediated via variation in As metabolism
(Vahter 2002).
iAs is metabolized by most mammals,
including humans, via reduction and methyla-
tion reactions with S-adenosylmethionine
(SAM) as the methyl donor (Hayakawa et al.
2005; Marafante and Vahter 1984; Vahter
2002). Dimethylarsinic acid (DMA) is the
main As metabolite excreted in human urine,
besides monomethylarsonic acid (MMA) and
some remaining iAs, but there are major differ-
ences among individuals as well as between
population groups (Vahter 2002). Usually, the
proportions are 10–30% iAs, 10–20% MMA,
and 60–80% DMA (Vahter 2002). The
metabolism of As implies both detoxiﬁcation
and activation. The reduced trivalent forms, in
particular MMA(III), are more toxic than the
pentavalent forms (Bredfeldt et al. 2006;
Schwerdtle et al. 2003; Styblo et al. 2002;
Wang et al. 2007). A high concentration of
MMA in the urine indicates a low capacity of
further methylation to DMA and, probably,
elevated concentrations of the highly toxic
MMA(III) in the cells. There is increasing evi-
dence of positive associations between urinary
MMA and the prevalence of As-related bladder
cancer (Chen et al. 2003b; Pu et al. 2007;
Steinmaus et al. 2006), skin cancer (Chen
et al. 2003a; Hsueh et al. 1997; Yu et al.
2000), other skin effects (Ahsan et al. 2007;
Del Razo et al. 1997), structural chromosomal
aberrations (Maki-Paakkanen et al. 1998),
cardiovascular effects (Tseng et al. 2005), and
increased retention of ingested As (Vahter
2002). Thus, it is essential to identify the
mechanisms behind the wide interindividual
variation in As metabolism. 
Because As is methylated through one-
carbon metabolism (Figure 1), it is likely that
the availability of methyl groups via intake of
protein (Lammon and Hood 2004; Marafante
and Vahter 1984; Vahter and Marafante
1987) and other factors involved in the methy-
lation cycles [e.g. folate and vitamin B12
(Spiegelstein et al. 2003; Spiegelstein et al.
2005)] are critical for As methylation. There is
also experimental evidence for the involvement
of essential trace elements such as selenium
and zinc (De Kimpe et al. 1999; Hong et al.
2000; Walton et al. 2003), although the mech-
anisms are not clear. Because of the marked
species differences in As methylation (Vahter
1999), it is difﬁcult to extrapolate the results to
humans. However, there is growing evidence
for a nutritional regulation of As methylation
in humans (Gamble et al. 2005, 2006, 2007;
Heck et al. 2007; Steinmaus et al. 2005). In
the present study, we aimed to elucidate the
modifying effects of macronutrient status,
assessed by body mass index [BMI; body
weight (kg) ÷ height (m2)], and micronutrient
status, assessed by biomarkers of folate, vita-
min B12, Zn, ferritin, and Se status, on As
metabolism in pregnant Bangladeshi women
with a wide range of nutritional status and As
exposure via drinking water. 
Methods
Study area and population. Our ongoing
research project concerning the effects of As
exposure via drinking water on reproduction
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BACKGROUND: The interindividual variation in metabolism of inorganic arsenic (iAs), involving
methylation via one-carbon metabolism, has been well documented, but the reasons remain
unclear. 
OBJECTIVES: In this population-based study we aimed to elucidate the effect of nutrition on As
methylation among women in Matlab, Bangladesh, where people are chronically exposed to iAs via
drinking water. 
METHODS: We studied effects of macronutrient status using body mass index (BMI) among 442
women in early pregnancy (gestational week 8), and effects of micronutrient status (plasma folate,
vitamin B12, zinc, ferritin, and selenium) among 753 women at gestational week 14. Arsenic metabo-
lites in urine were measured by HPLC combined with hydride generation inductively coupled plasma
mass spectrometry. 
RESULTS: The median concentration of As in urine was 97 µg/L (range, 5–1,216 µg/L, adjusted by
speciﬁc gravity). The average proportions of iAs, monomethylarsonic acid, and dimethylarsinic acid
in urine in gestational week 8 were 15%, 11%, and 74%, respectively. Thus, the women had efﬁ-
cient As methylation in spite of being poorly nourished (one-third had BMIs < 18.5 kg/m2) and
having elevated As exposure, both of which are known to decrease As methylation. The metabolism
of iAs was only marginally inﬂuenced by micronutrient status, probably because women, especially
in pregnancy and with low folate intake, have an efﬁcient betaine-mediated remethylation of homo-
cysteine, which is essential for an efﬁcient As methylation. 
CONCLUSIONS: In spite of the high As exposure and prevalent malnutrition, overall As methylation
in women in early pregnancy was remarkably efficient. The As exposure level had the greatest
impact on As methylation among the studied factors.
KEY WORDS: arsenic, metabolite, methylation, nutrition, pregnant women, urine. Environ Health
Perspect 116:315–321 (2008). doi:10.1289/ehp.10639 available via http://dx.doi.org/ [Online
19 November 2007]and child development is being carried out in
Matlab, Bangladesh, where most of the
approximately 200,000 inhabitants drink
water from local tube wells, many of which
contain high concentrations of naturally
occurring As (Jakariya et al. 2005; Rahman
et al. 2006b). Most of the tube wells were
constructed in the 1970s and 1980s; thus,
many of the younger residents have been
exposed since birth.
This study on nutrition modiﬁcation of As
metabolism is nested into a population-based
food and micronutrient supplementation trial
[Maternal and Infant Nutrition Interventions
of Matlab (MINIMat)] carried out by the
International Center for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) in Matlab,
about 50 km southeast of Dhaka. This study
includes approximately 4,500 women who
enrolled in early pregnancy and were followed
until 6 months postpartum. Pregnancy was
identified by test of urine [gestational week
(GW) 6–8] from women reporting amenor-
rhea at the time of the monthly visit by com-
munity health research workers within the
Health and Demographic Surveillance System
(HDSS) that ICDDR,B has been running in
Matlab since the 1960s (Gwatkin et al. 2000).
At the time of enrollment (around GW9),
women were randomly assigned to be
included in a community-based food supple-
mentation program directly after conﬁrmation
of pregnancy by ultrasound (“early start”) or at
the time of their own choice (“usual start”),
about GW17. The supplemental food con-
sisted of fried rice powder (80 g), fried pulse
powder (40 g), molasses (20 g), and soybean
oil (12 mL). 
In the MINIMat trial, a total of 2,119
women were enrolled from January 2002
through December 2002. The loss of subjects
from pregnancy testing until enrollment was
about 29%; the main causes were refusal to
participate, a false-positive pregnancy test,
ineligibility for supplementation because of
gestational age criteria (above GW13), early
fetal loss or abortion, out-migration, or the
woman could not be located. Women who
were not enrolled were slightly older (by
about 6 months) and had slightly lower socio-
economic status (SES) than the women who
were enrolled. More details concerning back-
ground information, recruitment, and urine
sampling have been described in a previous
publication concerning the extent of As expo-
sure (Vahter et al. 2006). We obtained SES
from the HDSS.
One thousand of the women enrolled in
the MINIMat trial between January and
December 2002 (n = 2,119) were randomly
selected for assessment of micronutrients in
blood samples collected during GW14. This
cohort of 1,000 women was also used for fur-
ther analyses of As metabolites in urine.
Although all women were included for analy-
ses of the effects of micronutrients on As
metabolism, a subset of the ﬁrst 500 women
selected was used for the assessment of the
effect of macronutrient status. A selection
scheme for the women studied is shown in
Figure 2. For evaluation of the effect of
macronutrient status assessed by BMI, which
is often affected in early pregnancy, we used
urine samples collected in GW8 on average.
Of the first 500 randomly selected women,
442 had donated urine specimens and had
their body weight and height measured at the
time of pregnancy testing. Because of lack of
data on protein intake in the studied women,
we included urinary creatinine (U-Cre) con-
centrations as an additional proxy indicator of
macronutrient status, as it is related to muscle
mass and intake of meat (Suwazono et al.
2005). Although the gold standard is to meas-
ure creatinine in 24-hr urine, we adjusted the
concentrations in our spot urine samples by
speciﬁc gravity to compensate for variation in
urine dilution. 
For evaluation of the effect of micro-
nutrient status, we used urine and blood sam-
ples collected in GW14, when the blood
samples for measurements of nutritional
markers were collected. Out of the 1,000 ran-
domly selected pregnant women, 780 donated
both blood and urine specimens. Twenty-
seven urine samples in GW14 (but none in
GW8) had a specific gravity of 1.001 g/mL,
indicating highly diluted urine samples.
Therefore, we excluded those samples (3.5%
of the total number of 780 samples) from fur-
ther analysis. Thus, we included 442 women
in the macronutrient-effect analysis and
753 women in the micronutrient-effect analy-
sis, with 341 women included in both. 
Determination of As metabolites. We
assessed As metabolism using the percentages
of iAs, MMA, and DMA in urine, as well as
two methylation indexes [i.e., primary methy-
lation index (PMI), defined as the ratio
between MMA and iAs, and secondary
methylation index (SMI), deﬁned as the ratio
between DMA and MMA. We used total uri-
nary As [U-As; the sum of As metabolites (iAs
+ MMA + DMA) in urine] as the measure of
iAs exposure. Concentrations of As metabo-
lites in urine were measured with an Agilent
1100 HPLC system (Agilent Technologies,
Waldbronn, Germany), coupled with hydride
generation (HG) inductively coupled plasma
mass spectrometry (ICPMS) (Agilent 7500ce
series; Agilent Technologies, Japan). The
method measures metabolites of iAs [iAs(III),
iAs(V), MMA, and DMA], but not organic As
species (e.g., arsenobetaine, arsenocholine)
originating from the diet, because those arseni-
cals do not form volatile arsines (hydride gen-
eration) like iAs and its metabolites do. The
method was described in detail by Lindberg
et al. (2006). Determination limits were 0.1
µg/L for arsenite [As(III)] and MMA and
0.2 µg/L for DMA and arsenate [As(V)]. We
adjusted As concentrations for variations in
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Figure 1. Overview of one-carbon metabolism and the methylation of As. Abbreviations: 5,10-CH2-THF,
methylene tetrahydrofolate; AS3MT, As methyltransferase; DMG, dimethylglycine; GAA, guanidinoacetate;
MTHFR, 5,10-CH2-THF reductase; SAH, S-adenosylhomocysteine; THF, tetrahydrofolate. Methionine, which
originates from dietary protein and tissue protein, is activated by methionine adenosyltransferase to form
SAM, which provides methyl groups for most methylation reactions in the body (e.g., methylation of DNA,
GAA to creatine, and iAs to MMA and DMA). Methyltransferases are required for the methylation reac-
tions, in which SAH is formed. SAH is hydrolyzed to homocysteine, which is used either for regeneration of
methionine or for glutathione (GSH) biosynthesis in a transsulfuration pathway. In one methionine regen-
eration pathway, the methyl group is transferred to homocysteine from 5-CH3-THF and catalyzed by vita-
min B12. In the alternate pathway, the methyl group is transferred from betaine and catalyzed by
betaine:homocysteine methyltransferase (BHMT). 
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5-CH2-THFdilution by speciﬁc gravity (to the mean value
of 1.012 g/mL); U-Cre, which is commonly
used for dilution adjustment, was inﬂuenced
more by age and nutrition than was specific
gravity, and U-Cre was also associated with
urinary As (Nermell et al. 2007). 
For quality control purposes, we analyzed
the reference material (CRM No. 18; National
Institute for Environmental Studies, Ibaraki,
Japan) with a certiﬁed DMA concentration of
36 ± 9 µg/L together with the collected urine
samples. The concentration of DMA was
41 ± 3.4 µg/L (mean ± SD; n = 18). Urine
samples were also analyzed for As metabolites
by atomic ﬂuorescence spectrometry (AFS) and
for the sum of As metabolites by atomic
absorption spectrometry (AAS), as reported by
Lindberg et al. (2007a). The results of ICPMS
and AFS showed good agreement for all
metabolites; for iAs [As(III) + As(V)], MMA,
and DMA, R2 = 0.91, 0.91, and 0.97, respec-
tively (n = 221). Further, we obtained good
agreement for the sum of As metabolites
between the three different methods (for
ICPMS vs. AFS, R 2 = 0.97; for ICPMS vs.
AAS, R2 = 0.96 (n = 221). 
Measurement of nutrient status. Venous
blood samples were collected in GW14 at the
Matlab health clinics, where they were kept at
6–8°C until transported (within 4 hr) to the
hospital laboratory for separation of plasma,
which was stored at –70°C until analysis of
micronutrients at the University of California,
Davis. We measured plasma ferritin (P-Ft)
using radioimmunoassay (Diagnostic Products,
San Diego, CA, USA), and plasma Zn (P-Zn)
and plasma Se (P-Se) by AAS (Clegg et al.
1981). Ferritin values < 15 µg/L are usually
considered to reflect low iron stores (WHO
2001). The cutoff level for Zn deficiency in
pregnant women is 0.5 mg/L (Hotz et al.
2003), and the cutoff for low P-Se concentra-
tions is 60 µg/L (0.75 µmol/L) (Van Dael and
Deelstra 1993). Plasma folate (P-folate) and
vitamin B12 (P-B12) were determined by the
SimulTRAC-SNB radioassay kit (MP
Biomedicals, Orangeburg, NY, USA). P-folate
values < 4 µg/L (9 nmol/L) are considered
indicative of folate deficiency (Gamble et al.
2006); the cutoff level for vitamin B12 defi-
ciency is 0.25 µg/L (185 pmol/L) (Gamble
et al. 2005). Urinary creatinine was analyzed
by the Jaffé method. 
Statistical methods. We used Spearman’s
rank correlation analysis to assess bivariate asso-
ciations for identiﬁcation of predictors of As
metabolism and of potential confounding fac-
tors for further exploration in multivariate lin-
ear regression and analyses of covariance
(ANCOVA). The tested potential confound-
ing factors included As exposure (U-As), age,
BMI, SES, parity, and GW. The factors with
p-values < 0.1 in the bivariate tests were
included in the further multivariate analyses.
The exposure to As, age, SES, and BMI were
considered the potential confounding factors;
the ﬁnal inclusion of confounders are noted in
the tables. We used logarithmic transformation
of variables when needed to meet the require-
ments of equal variances and to achieve
approximately normal distribution. ANCOVA
was used with categorical independent vari-
ables adjusted for continuous covariates for
testing the difference in subgroups. A p-value
< 0.05 was considered signiﬁcant. For the sta-
tistical analyses, we used STATISTICA 7.1
(StatSoft Inc., Tulsa, OK, USA). 
Ethics. The study was approved by the
Regional Ethical Committee at the Karolinska
Institute and the Ethical Review Committee at
ICDDR,B, Bangladesh. The study complies
with applicable requirements of international
ethical regulation. Informed consent was
received prior to study start. The As-related
ethical issues are described in more detail else-
where (Vahter et al. 2006).
Results
Characteristics of the participants. The charac-
teristics of the women are presented in Table 1.
The 442 women included in the macro-
nutrient study had their ﬁrst urine samples col-
lected in GW8 (range, 4.4–20 weeks;
10th/90th percentiles 5.9/11.4 weeks), whereas
the 753 women in the micronutrient study had
their second urine samples and blood collected
in GW14 (range, 9.1–22 weeks; 10th/90th
percentiles 12.5/16.5 weeks). The two groups
were very similar with regard to recorded per-
sonal characteristics, except for body weight,
which because of pregnancy was slightly higher
in GW14. Mean age was 27 years (range,
14–44 years), with body weight of 45 kg
(range, 30–72 kg) in GW8, height of 150 cm
(range, 125–170 cm), and parity of 1.5 (range,
0–8 children); the women had on average
5 years of formal school education. Mean BMI
was 19.9 kg/m2 (range, 13.9–32.0) in GW8
and 20.3 kg/m2 (range, 14.1–29.2 kg/m2) in
GW14. The mean U-Cre concentration in
GW8 was 0.57 g/L (range, 0.10–1.6 g/L),
adjusted to an average specific gravity of
1.012 g/L. Mean (± SD) plasma concentra-
tions were 5.1 ± 3.0 µg/L for P-folate, 0.23 ±
0.12 µg/L for P-B12, 0.61 ± 0.25 mg/L for
P-Zn, and 35 ± 25 µg/L for P-Ft. About 60%
of women were deﬁcient in vitamin B12, 40%
in folate, 30% in Zn, and 20% in iron (low
ferritin). A subsample analyzed for P-Se
showed a mean of 60 ± 11 µg/L (n = 89,
randomly selected). 
Variation in As exposure and metabolism.
The median concentration of total U-As in
GW8 was 97 µg/L (mean, 159 µg/L),
Nutrition and arsenic in Bangladeshi women 
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Table 1. General characteristics of subjects in the
macronutritional (GW8; n = 442) and micronutritional
analyses (GW14; n = 753).
Macronutritional Micronutritional
analyses analyses
[No. (%)] [No. (%)]
Age (years)
< 19.9 73 (16.5) 110 (14.6)
20–24.9 111 (25.1) 214 (28.4)
25–29.9 135 (30.5) 217 (28.8)
≥ 30 123 (27.8) 212 (28.2)
Unknown 0 (0.0) 0 (0.0)
Weight (kg)
< 39.9 98 (22.2) 128 (17.0)
40–49.9 258 (58.4) 446 (59.2)
50–59.9 64 (14.5) 138 (18.3)
≥ 60 20 (4.5) 19 (2.5)
Unknown 2 (0.5) 22 (2.9)
BMI (kg/m2) 
< 18.5 135 (30.5) 179 (23.8)
18.5–25 281 (63.6) 521 (69.2)
> 25 24 (5.4) 31 (4.1)
Unknown 2 (0.5) 22 (2.9)
SESa 
Poorest 79 (17.9) 137 (18.2)
Second 94 (21.3) 174 (23.1)
Middle 103 (23.3) 153 (20.3)
Fourth 73 (16.5) 136 (18.1)
Richest 93 (21.0) 153 (20.3)
Unknown 0 (0.0) 0 (0.0)
aQuintiles of constructed wealth index based on asset
ownership. 
Figure 2. Selection of participants to studies of effects of macronutrient and micronutrient status on As
metabolism.
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(n = 753)adjusted by specific gravity (1.012 g/mL),
with a total range of 5–1,216 µg/L (10th per-
centile, 19 µg/L; 90th percentile, 385 µg/L).
The mean ± SD proportions of iAs, MMA,
and DMA in urine in GW8 were 15 ± 9.5%,
(9.5), 11 ± 4.3%, and 74 ± 10.5%, respec-
tively. We also found a considerable inter-
individual variation in the distribution of the
metabolites (Figure 3). The 10th and 90th
percentiles were 7 and 24% for %iAs, 5 and
17% for %MMA, and 62 and 85% for
%DMA. A similar variation in U-As metabo-
lites was seen in GW14. The mean ± SD pro-
portions of iAs, MMA, and DMA in urine in
GW14 were 14 ± 6.9%, 8 ± 3.1%, and 79 ±
7.9%, respectively. 
In the bivariate analysis intended for
detection of predictors of As methylation and
potential confounders, only As-exposure was
markedly associated with percentages of iAs,
MMA, DMA, and SMI (p < 0.001). Age was
weakly associated with %iAs (rs = –0.09,
p = 0.05 at GW8; rs = –0.08, p = 0.03 at
GW14), SES with PMI (rs = 0.07, p = 0.1 at
GW8; rs = 0.15, p < 0.001 at GW14), and
BMI weakly associated with %DMA and SMI
(rs = 0.06, p = 0.1 and rs = 0.05, p = 0.1,
respectively at GW14). Because the As expo-
sure level appeared to inﬂuence metabolism in
a nonlinear way, as previously shown
(Lindberg et al. 2008; Vahter 2002), we evalu-
ated the distribution of the various metabolites
by tertiles of U-As, representing low,
medium, and high exposure (Table 2). The
distribution of all the measured metabolites in
urine in GW8 was highly inﬂuenced by U-As.
After adjustment for age, BMI, and SES, the
mean %iAs and %MMA increased and mean
%DMA decreased signiﬁcantly with increas-
ing concentration of U-As (p < 0.01).
Moreover, PMI was positively associated with
the exposure (p < 0.05), whereas SMI was
negatively associated with the exposure
(p < 0.01). Essentially the same pattern was
seen in GW14. 
Influence of macronutrient status on As
metabolism. Because of the observed inﬂuence
of the exposure to As on its metabolism, we
adjusted for U-As in the evaluation of effects of
macronutrient and micronutrient status on As
methylation. A potential nonlinear relation
between BMI (marker of macronutrient status)
and As metabolites was evaluated by tertiles of
U-As adjusting for age and SES. We found no
significant association between BMI and the
percentages of As metabolites or methylation
indexes (p > 0.05). To test a potential linear
relation between BMI and As metabolites
(%iAs, %MMA, %DMA, PMI, or SMI) we
applied multiple linear regression analyses,
adjusting for U-As, age, and SES; this method
also did not show any signiﬁcant association.
In contrast, U-Cre (adjusted by speciﬁc grav-
ity) was signiﬁcantly associated with most of
the dependent variables when tested in a simi-
lar multiple linear regression analysis, despite a
significant association between BMI and
U-Cre (Spearman’s rank correlation tests,
rs = 0.20, p < 0.001). With increasing U-Cre,
the %iAs decreased (p < 0.01) and the %DMA
(R2 = 0.19, p < 0.05), PMI, and SMI increased
(p < 0.01). 
Influence of micronutrient status on As
metabolism. Mean values of %iAs, %MMA,
%DMA, PMI, and SMI were adjusted for age,
BMI, and SES for different exposure levels
(U-As stratified into tertiles); micronutrient
indicators are shown in Table 3. The %iAs
decreased with increasing P-folate concentra-
tion (13.4% in the first tertile of P-folate
against 15.9% in the third tertile; p < 0.05) at
the highest exposure level (third tertile of UAs;
i.e., > 209 µg/L). No clear associations were
seen between P-B12 or P-Ft and the percent-
ages of As metabolites and methylation
indexes, except for an indicated trend of
decreasing %iAs with increasing level of
P-B12 at the second tertile of exposure
(58–209 µg/L). We found no overall associa-
tion with P-Zn; however, at the highest As
exposure level, %iAs and %MMA were higher
and %DMA was lower at the highest Zn levels
(p < 0.05). 
Thirty-eight women had low folate, as well
as low vitamin B12 and Zn (deﬁcient group; all
in the lowest tertiles: P-folate < 3.8 µg/L;
P-B12 < 0.16 µg/L; P-Zn < 0.50 mg/L),
whereas 36 women had adequate levels of all
three micronutrients (adequate group; all in
the highest tertiles: P-folate ≥ 5.3 µg/L; P-B12
≥ 0.26 µg/L; P-Zn ≥ 0.64 mg/L). The defi-
cient group had a slightly higher percentage of
iAs in urine (14.3% vs. 12.0%; p < 0.05) and a
lower PMI (0.43 vs. 0.61; p < 0.05) after con-
trolling for age, BMI, and SES. The U-As
(median values 96 and 126 µg/L, respectively),
%MMA (6.2 and 7.4%, respectively), and
%DMA (77.7 and 77.1%, respectively) were
similar in deﬁcient and adequate groups. 
Multiple linear regression analysis, includ-
ing U-As, age, BMI, and SES, showed that
P-Se was not associated with any of the As
metabolites or methylation indexes (p > 0.05;
n = 89). 
Discussion
In contrast to the hypothesis, the results of
this large population-based study show that
the metabolism of iAs in rural Bangladeshi
women in early pregnancy is only marginally
influenced by nutritional status. In spite of
the prevalent malnutrition, the Matlab
women had a remarkably efficient methyla-
tion of As. The mean percentage of DMA
(74%) in urine in GW8 was in the upper
range of that observed in many populations in
developed countries with much better nutri-
tional status (Vahter 2002). Even in women
Li et al.
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Table 2. Adjusteda mean values of %iAs, %MMA, %DMA, PMI, and SMI stratiﬁed by urinary As (µg/L, tertiles)
in GW8.
U-As (µg/L)  No. %iAs  %MMA  %DMA  PMI  SMI 
< 48 147 11.6 8.6 78.3 0.69 9.84
48–174 147 14.0 9.4 72.1 0.67 7.64
≥ 174 148 15.4 13.1 69.1 0.81 5.59
p-Value < 0.01 < 0.01 < 0.01 < 0.05 < 0.01
aUsing ANCOVA to analyze the effects of categorical independent variable of As exposure levels presented by tertiles of
U-As and adjusted for age, SES, and BMI as continuous covariates. 
Figure 3. Frequency distribution of As metabolites in urine, demonstrating the interindividual variability in
As metabolism among 442 pregnant women in GW8.
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%MMAdeficient in folate, vitamin B12, and Zn, the
As methylation efﬁciency was still very good,
with > 75% DMA in the urine. The average
proportions of the urinary metabolites of As
(15, 11, and 74% for %iAs, %MMA, and
%DMA, respectively) are similar to those
reported for female subjects in Araihazar, a
region approximately 30 km east of Dhaka,
Bangladesh (Gamble et al. 2005); this shows
that efﬁcient As methylation is not a particu-
lar feature of the Matlab area. 
Previous studies in Bangladeshi men and
women, however, showed a much stronger
association (positive) between plasma folate
and %DMA in urine (Gamble et al. 2005). In
addition, folic acid supplementation caused a
signiﬁcant increase in urinary %DMA and a
decrease in %MMA (Gamble et al. 2006). A
likely reason for the lower nutritional inﬂuence
on As metabolism in the present study is that
women in childbearing age have a more efﬁ-
cient methylation of As than men (Lindberg
et al. 2007b), particularly during pregnancy
(Concha et al. 1998; Hopenhayn et al. 2003).
This may be related to the de novo synthesis in
women of choline by phosphatidylethanol-
amine methyltransferase (Vahter 2007), which
is up-regulated by estrogen (Fischer et al.
2007). Choline is oxidized to betaine, which
can donate its methyl group to homocysteine
to form methionine (Figure 1). This reaction,
catalyzed by betaine:homocysteine methyl-
transferase, is the sole alternate route to the
folate-dependent methionine synthase–
catalyzed homocysteine remethylation (Ueland
et al. 2005). Removal of homocysteine is a pre-
requisite for adequate one-carbon metabolism
and As methylation (Figure 1) because the pre-
cursor to homocysteine, S-adenosylhomo-
cysteine, is a strong feed-back inhibitor of the
SAM-dependent methylation reactions,
including the methylation of As (Marafante
and Vahter 1984). Because there is a close
interconnection between folate, vitamins B12
and B6, choline, betaine, and methionine in
the human methylation pathway (Niculescu
and Zeisel 2002; Stead et al. 2006; Ueland
et al. 2005), the betaine-mediated remethyla-
tion of homocysteine is especially important in
individuals with low folate intake, which was
the case for many of the women in the present
study. Gamble et al. did not report the effect of
micronutrient status by sex, but they showed
that women had higher %DMA than men
(Gamble et al. 2005). We recently reported
that BMI was positively associated with urinary
%DMA and negatively associated with
%MMA in men but not in women (Lindberg
et al. 2007b); this supports our conclusion that
women are less sensitive to poor nutrition for
the methylation of As. This implies that
women are also less susceptible to the health
risks associated with high %MMA in urine, as
discussed above. In fact, women seem to be less
susceptible than men to As-induced skin effects
(Rahman et al. 2006a; Vahter et al. 2007) and
respiratory tract diseases (Smith et al. 2006;
von Ehrenstein et al. 2005). 
The fact that the women in the present
study were pregnant also may have contributed
to the marginal effect of nutrition on As
methylation. In pregnancy, the endogenous
synthesis of choline is particularly induced to
meet the fetal demand of large amounts of
choline for tissue growth and brain develop-
ment (Zeisel 2006b), which may explain, at
least in part, the increase in As methylation in
pregnancy (Concha et al. 1998; Hopenhayn
et al. 2003). The increase in plasma choline
levels starts early in pregnancy and continues
until term (Velzing-Aarts et al. 2005; Zeisel
2006a). Plasma betaine decreases from early in
the ﬁrst trimester until about GW20, and there
is an increasing inverse betaine–homocysteine
relation, emphasizing the importance of
betaine in one-carbon metabolism in early
pregnancy (Velzing-Aarts et al. 2005).
Unfortunately, we did not measure plasma
choline or betaine in the present study, but it
seems likely that the betaine-mediated
remethylation of homocysteine had started to
increase, as many of the women were in their
second trimester. There was an indication of
higher %DMA in GW14 compared with
GW8, and this will be further evaluated in a
longitudinal study. An interesting parallel to
the present results is the reported lack of
changes in global liver DNA methylation in rat
dams (and their fetuses) fed a folate-deﬁcient
diet with low methionine and choline content
(Maloney et al. 2007). The folate deficiency
was found to increase the liver choline at the
expense of phosphocholine stores.
Of the factors evaluated in the present
study, the As exposure level appeared to have
the greatest impact on As methylation. With
increasing exposure level, the proportion
of iAs and MMA in urine increased and the
proportion of DMA decreased, which is in
line with previous in vitro studies (De Kimpe
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Table 3. Adjusteda mean values of %iAs, %MMA, %DMA, PMI, and SMI at GW14 stratiﬁed by U-As (tertiles),
P-folate, P-B12, P-Zn, and P-Ft.
U-As (µg/L)  Micronutrients No. U-As (µg/L) %iAs %MMA %DMA PMI SMI
P-folate (µg/L) 
< 58 < 3.8 76 32 10.8 5.9 81.7 0.54 13.91
3.8–5.3 88 34 9.9 6.2 81.9 0.63 13.12
> 5.3 81 32 10.0 6.8 81.0 0.69 11.87
58–209 < 3.8 86 117 12.9 7.0 77.3 0.54 11.07
3.8–5.3 89 109 13.5 6.6 77.7 0.49 11.83
> 5.3 80 108 11.8 6.5 78.8 0.55 12.07
> 209 < 3.8 78 360 15.9* 8.3 74.2 0.52 8.92
3.8–5.3 85 370 14.1 8.1 75.4 0.58 9.28
> 5.3 83 383 13.4* 7.8 75.9 0.58 9.72
P-B12 (µg/L) 
< 58 < 0.16 94 33 10.5 6.3 81.3 0.60 12.95
0.16–0.26 80 34 10.7 6.1 81.1 0.56 13.41
> 0.26 68 32 9.5 6.6 82.0 0.70 12.40
58–209 < 0.16 87 113 13.7 6.9 76.5 0.50 11.12
0.16–0.26 82 110 12.7 6.7 78.2 0.53 11.60
> 0.26 74 108 11.7 6.3 79.2 0.54 12.56
> 209 < 0.16 62 381 14.8 7.5 75.0 0.50 10.06
0.16–0.26 81 355 14.8 8.3 74.7 0.56 8.97
> 0.26 101 385 13.9 8.2 75.7 0.59 9.21
P-Zn (mg/L) 
< 58 < 0.50 79 35 10.5 6.2 81.1 0.58 13.17
0.50–0.64 88 33 10.4 6.0 81.5 0.57 13.69
> 0.64 84 31 9.7 6.9 81.9 0.71 11.90
58–209 < 0.50 97 112 13.4 6.7 76.9 0.50 11.47
0.50–0.64 81 113 12.1 6.4 78.7 0.53 12.33
> 0.64 72 110 12.6 7.0 78.3 0.56 11.18
> 209 < 0.50 73 373 14.4 7.4* 76.5* 0.51* 10.3*
0.50–0.64 82 350 13.1* 8.2 76.7* 0.62* 9.37
> 0.64 95 392 15.8* 8.5* 72.7* 0.54 8.5*
P-Ft (mg/L) 
< 58 < 21 81 31 10.1 6.3 81.7 0.62 13.03
21–38 80 35 9.9 5.9 82.0 0.60 13.82
> 38 85 33 10.4 6.8 81.2 0.65 12.01
58–209 < 21 92 115 12.5 7.2 78.4 0.57 10.90
21–38 76 103 12.3 6.4 78.5 0.52 12.33
> 38 82 116 13.4 6.5 76.7 0.48 11.83
> 209 < 21 76 339 14.3 7.5 76.6 0.52 10.23
21–38 93 387 14.4 8.6 74.2 0.60 8.59
> 38 82 390 14.8 8.1 74.9 0.55 9.29
aAdjusted for age, BMI, and SES. *p < 0.05 between indicated tertiles of plasma nutrient levels.et al. 1999; Styblo et al. 2000) and epidemio-
logic studies (Hopenhayn-Rich et al. 1996;
Lindberg et al. 2008). These results indicate
that excess As inhibits the methyltransferases
involved in As methylation, especially the
methylation from MMA to DMA. We found
that the increase in %MMA started at very
low As exposure levels, corresponding to about
50 µg/L in urine; this is an important new
finding because elevated MMA is a known
risk factor for a wide range of As-related health
effects (for review, see Tseng 2007). 
Because of the lack of data on protein
intake in the present study, we included U-Cre
as a proxy indicator of macronutrient status
because it is related to the muscle mass and
meat intake (Suwazono et al. 2005). As
expected, we found a significant correlation
between U-Cre and BMI; U-Cre was much
lower in the malnourished Matlab women
(average, 0.57 g/L) than in populations with
adequate nutritional status [median, 0.96 g/L
in pregnant UK women during the entire ges-
tation period (Waugh et al. 2003); 0.93 g/L in
Swedish women during GW11–12 and
0.66 g/L during GW36–37 (Akesson et al.
2002)]. Interestingly, we found a positive asso-
ciation between U-Cre and %DMA, similar to
ﬁndings in another recent study in Bangladesh
(Gamble and Liu 2005). As we found no asso-
ciation between BMI and %DMA, we tend to
believe that the correlation between U-Cre and
%DMA is related to the fact that both U-Cre
and DMA are products of the general methyla-
tion pathway using SAM as methyl donor.
This was proposed by Gamble et al. (2005) in
a study from Bangladesh in which urinary crea-
tinine was the strongest predictor of As methy-
lation, particularly for males. Methylation in
the liver of guanidino-acetate to creatine, the
precursor of creatinine, is the most important
methylation reaction in the one-carbon methy-
lation cycle from a quantitative point of view
(Mudd and Poole 1975; Stead et al. 2006). 
The main strength of this population-based
study is the high number of women with a
wide range of As exposures and nutritional sta-
tus for which we were able to assess individual
biomarker data, in combination with detailed
data on anthropometry and SES. Further, the
study population is fairly homogeneous, that is,
rural Bangladeshi women in early pregnancy
with essentially no smoking (< 1%) or alcohol
consumption. In addition, the metabolism of
As was assessed by the pattern of As metabolites
in urine, determined by a sensitive HPLC-HG-
ICPMS method. The limitations of the study
include the wide range of GWs at the time of
plasma and urine sampling, which may poten-
tially influence the plasma concentrations of
nutrients, especially folate and iron. However,
we found no signiﬁcant change in plasma folate
by GW(< GW12.5, 4.3 µg/L; GW12.5–16.5,
4.5 µg/L; > GW16.5, 4.6 µg/L). Also, the likely
start of some women in the food supplementa-
tion trial might have influenced their nutri-
tional status. However, because we evaluated
associations between biomarkers of As exposure
and nutrient status and found very weak associ-
ations, this is not likely to have inﬂuenced the
overall results. Another disadvantage is the lim-
ited amounts of collected plasma, which did
not allow us to measure other micronutrients
essential for one-carbon metabolism. 
In conclusion, nutrition accounted for a
minor part of the interindividual variation in
As methylation in these highly exposed mal-
nourished Bangladeshi women in early preg-
nancy. The average As methylation efﬁciency
was unexpectedly high; we propose that this is
related to the de novo synthesis of choline,
which is essential for one-carbon metabolism
and As methylation, especially in women with
low folate intake and during pregnancy.
Polymorphisms in As methyltransferases (e.g.,
AS3MT) and As(V) and MMA(V) reductases
(e.g., hGSTO1) are likely to explain more of
the observed variation in As metabolism, as
found in our ongoing research involving pop-
ulation groups in Central Europe and
Argentina (Lindberg et al. 2007b; Schlawicke
Engstrom et al. 2007). 
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